NCT03830892

Brief Summary

This study aims to understand the effects of device power and nicotine concentration on the likelihood that someone would use or abuse e-cigarettes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2019

Completed
4 days until next milestone

Study Start

First participant enrolled

January 18, 2019

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 5, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 6, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 6, 2020

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

June 4, 2021

Completed
Last Updated

June 4, 2021

Status Verified

May 1, 2021

Enrollment Period

1.1 years

First QC Date

January 14, 2019

Results QC Date

March 16, 2021

Last Update Submit

May 10, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Breakpoint of Drug Purchase Tasks (DPT)

    The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session. Each DPT will be completed once per study session (either 90 minutes or approximately 180 minutes into the session, timing varies based on task order presentation and potentially choices made in tasks presented prior to this task).

    Up to 180 minutes

  • Breakpoint of Multiple Choice Procedure (MCP)

    The MCP will yield of measure of willingness to pay for session-specific tobacco products. One choice made during this task is reinforced (i.e., money or tobacco product is distributed). Completed once per study session (either 90 minutes or approximately 180 minutes into the session, timing varies based on task order presentation and potentially choices made in tasks presented prior to this task).

    Up to 180 minutes.

  • Effort for Product Puffs With the Progressive Ratio Task (PRT)

    The PRT will yield a measure of willingness to work for session-specific tobacco products (via number of times a space bar is pressed to earn puffs) by measuring the number of puffs self-administrated. Completed once per study session (either 90 minutes or approximately 180 minutes into the session, timing varies based on task order presentation and potentially choices made in tasks presented prior to this task).

    Up to 180 minutes.

Other Outcomes (7)

  • Subjective Measures of Nicotine Abstinence Symptoms

    First measure given, regardless of task order, 90 minutes into each session

  • Subjective Measures of Nicotine Abstinence Symptoms

    Third measure given during each session, approximately 120 minutes into each session (timing dependent on choices made in tasks presented prior to this measure).

  • Subjective Measures of Nicotine Abstinence Symptoms

    Fifth measure given during each session, approximately 180 minutes into each session (timing dependent on choices made in tasks presented prior to this measure).

  • +4 more other outcomes

Study Arms (2)

E-cigarette User (Exclusive)

ACTIVE COMPARATOR

Other: E-cigarette Lab Session 15 watts, 10 mg nicotine Other: E-cigarette Lab Session 15 watts, 30 mg nicotine Other: E-cigarette Lab Session 30 watts, 10 mg nicotine Other: E-cigarette Lab Session 30 watts, 30 mg nicotine Other: Own Brand Session - E-cigarette

Other: E-cigarette Lab Session 15 watts, 10 mg nicotineOther: E-cigarette Lab Session 15 watts, 30 mg nicotineOther: E-cigarette Lab Session 30 watts, 10 mg nicotineOther: E-cigarette Lab Session 30 watts, 30 mg nicotineOther: Own Brand Session - E-cigarette

Dual User

ACTIVE COMPARATOR

Other: E-cigarette Lab Session 15 watts, 10 mg nicotine Other: E-cigarette Lab Session 15 watts, 30 mg nicotine Other: E-cigarette Lab Session 30 watts, 10 mg nicotine Other: E-cigarette Lab Session 30 watts, 30 mg nicotine Other: Own Brand Session - E-cigarette/Cigarette

Other: E-cigarette Lab Session 15 watts, 10 mg nicotineOther: E-cigarette Lab Session 15 watts, 30 mg nicotineOther: E-cigarette Lab Session 30 watts, 10 mg nicotineOther: E-cigarette Lab Session 30 watts, 30 mg nicotineOther: Own Brand Session - E-cigaretteOther: Own Brand Session - E-cigarette/Cigarette

Interventions

E-cigarette paired with low nicotine, low device power

Dual UserE-cigarette User (Exclusive)

E-cigarette paired with low nicotine, low device power

Dual UserE-cigarette User (Exclusive)

E-cigarette paired with low nicotine, low device power

Dual UserE-cigarette User (Exclusive)

E-cigarette paired with low nicotine, low device power

Dual UserE-cigarette User (Exclusive)

E-cigarette paired with own brand liquid and preferred power

Dual UserE-cigarette User (Exclusive)

Own brand cigarette OR E-cigarette paired with own brand liquid and preferred power

Dual User

Eligibility Criteria

Age21 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy (determined by self-report)
  • between the ages of 21-55
  • willing to provide informed consent
  • able to attend the lab and abstain from tobacco/nicotine as required and must agree to use designated products according to study protocol

You may not qualify if:

  • Women if they are breast-feeding or test positive for pregnancy (by urinalysis) at screening.
  • Some study details about the eligibility criteria are purposely omitted at this time to preserve scientific integrity. Full details will be posted at the conclusion of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for the Study of Tobacco Products

Richmond, Virginia, 23220, United States

Location

Related Publications (2)

  • White AM, Bono RS, Lester RC, Underwood M, Hoetger C, Lipato T, Bickel WK, Cobb CO, Barnes AJ. The electronic nicotine delivery system (ENDS) purchase task: Are results sensitive to price framing? Exp Clin Psychopharmacol. 2023 Oct;31(5):895-901. doi: 10.1037/pha0000631. Epub 2022 Dec 8.

  • Hoetger C, Bono RS, White AM, Barnes AJ, Cobb CO. The interaction of nicotine concentration and device power on electronic nicotine delivery system (ENDS) abuse liability among exclusive ENDS users and dual users of ENDS and combustible cigarettes. Exp Clin Psychopharmacol. 2022 Dec;30(6):973-982. doi: 10.1037/pha0000523. Epub 2021 Oct 14.

MeSH Terms

Conditions

Vaping

Interventions

NicotineTobacco Products

Condition Hierarchy (Ancestors)

SmokingBehavior

Intervention Hierarchy (Ancestors)

Solanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsPyridinesHeterocyclic Compounds, 1-RingSmoking DevicesManufactured MaterialsTechnology, Industry, and Agriculture

Results Point of Contact

Title
Dr. Andrew J. Barnes
Organization
Virginia Commonwealth University

Study Officials

  • Caroline Cobb (Amey), PhD

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR
  • Andrew Barnes, PhD

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will be blinded to their condition (power level and nicotine concentration) used in each session, except during their 'own brand' session.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: We will recruit two populations of e-cigarette users: exclusive e-cigarette users and dual users of e-cigarettes and tobacco cigarettes. All participants complete 5 within-subject laboratory conditions that each last 4 hours. Conditions (sessions) differ by the tobacco product used: 1) e-cigarette with low device power, low nicotine mg/ml; 2) e-cigarette with low device power, high nicotine mg/ml; 3) e-cigarette with high device power, low nicotine mg/ml; 4) e-cigarette with high device power, high nicotine mg/ml; and 5) own brand e-cigarette/cigarette. The first four sessions are latin-square-ordered and the last session for all participants will be their own brand cigarette/e-cigarette depending on the population. For dual users, we will counter-balance own brand condition product assignment (cigarette vs. e-cigarette). Conditions will differ in the presentation of primary outcomes (task order) which will be counterbalanced.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2019

First Posted

February 5, 2019

Study Start

January 18, 2019

Primary Completion

March 6, 2020

Study Completion

March 6, 2020

Last Updated

June 4, 2021

Results First Posted

June 4, 2021

Record last verified: 2021-05

Locations